Assessing the impact of pneumococcal conjugate vaccine immunization schedule change from 3+0 to 2+1 in Australian children: a retrospective observational study Read more about Assessing the impact of pneumococcal conjugate vaccine immunization schedule change from 3+0 to 2+1 in Australian children: a retrospective observational study7 views
Annual Immunisation Coverage Report 2022 Read more about Annual Immunisation Coverage Report 202213 views
The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence Read more about The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence22 views
Immunisation health workforce capacity building in Southeast Asia: reflections from training programme implementation in Cambodia and Lao PDR Read more about Immunisation health workforce capacity building in Southeast Asia: reflections from training programme implementation in Cambodia and Lao PDR19 views
Influenza epidemiology and vaccine effectiveness following funded influenza vaccine in Queensland, Australia, 2022 Read more about Influenza epidemiology and vaccine effectiveness following funded influenza vaccine in Queensland, Australia, 202234 views
Glucocorticoid dosing and implications for vaccination: evolution of global definitions Read more about Glucocorticoid dosing and implications for vaccination: evolution of global definitions28 views
Accelerated Bacille Calmette-Guérin reactions: more than meets the eye Read more about Accelerated Bacille Calmette-Guérin reactions: more than meets the eye37 views
The Collaboration on Social Science and Immunisation (COSSI): global lessons from a successful Australian research and practice network Read more about The Collaboration on Social Science and Immunisation (COSSI): global lessons from a successful Australian research and practice network43 views
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines Read more about Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines47 views
ATAGI 2022 Annual Statement on Immunisation Read more about ATAGI 2022 Annual Statement on Immunisation67 views
